Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_24254 | 36 | 0.75 | Mlig455_022833, Mlig455_052911 | Neo: - Age: - |
Mlig455_022833 {REF} {Length: 3826} {RNA1509_37106} {RNA1310_20119} {RNA815_32661} Mlig455_052911 {REF} {Length: 373} {NoTransDecoderORF} {RNA1509_43679} {RNA1310_11574} {RNA815_11715.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.441 | 1.133 | 0.89352 | 1.00000 | |
RegionR2 | -0.065 | 1.133 | 0.94362 | 1.00000 | |
RegionR3 | -0.844 | 1.133 | 0.99183 | 1.00000 | |
RegionR4 | 0.441 | 1.133 | 0.63758 | 0.94413 | |
RegionR5 | -0.763 | 1.133 | 0.99022 | 1.00000 | |
RegionR6 | -0.934 | 1.133 | 0.99461 | 1.00000 | |
RegionR7 | 0.903 | 1.133 | 0.75116 | 1.00000 | |
RegionR8 | 1.703 | 1.133 | 0.47016 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.333 | 1.133 | 0.99995 | 1.00000 | |
RegenerationR2 | 1.14 | 1.133 | 0.30167 | 0.74335 | |
RegenerationR3 | -0.598 | 1.133 | 0.70322 | 0.94883 | |
RegenerationR4 | 0.585 | 1.133 | 0.85780 | 1.00000 | |
RegenerationR5 | -3.393 | 1.133 | 0.02817 | 0.28352 | |
RegenerationR6 | 1.073 | 1.133 | 0.48309 | 0.79376 | |
RegenerationBL | -2.769 | 1.133 | 0.38894 | 0.75735 | |
RegenerationTP | -5.299 | 1.133 | 0.04777 | 0.35915 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_24254 | 36 | 0.75 | Mlig455_022833, Mlig455_052911 | Neo: - Age: - |
5 | 1.000 | 1.000 | - | 1.000 | 1.000 | 1.000 | Mlig455_022833 {REF} {Length: 3826} {RNA1509_37106} {RNA1310_20119} {RNA815_32661} Mlig455_052911 {REF} {Length: 373} {NoTransDecoderORF} {RNA1509_43679} {RNA1310_11574} {RNA815_11715.1} |
|
2. | MligTC455_14934 | 36 | 0.76 | Mlig455_005168 | Neo: - Age: - Regeneration-upregulated R2: 5.261 Regeneration-enriched R2: 5.261 |
1.672 | - | - | - | 0.703 | 0.969 | - | Mlig455_005168 {REF} {Length: 1210} {RNA1509_7696} {RNA1310_27828} {RNA815_12648} | |
3. | MligTC455_47014 | 35 | 0.73 | Mlig455_050209 | Neo: - Age: - Region-enriched R3: 3.704/0.01149 |
PRODH2 | 0.998 | - | - | - | - | - | 0.998 | Mlig455_050209 {REF} {Length: 2665} {Pfam: Proline dehydrogenase [PF01619.20, score=169.6]} {Human: ENSG00000250799, PRODH2, proline dehydrogenase 2, [Score=196, Expect=2e-55]} {Mouse: ENSMUSG00000036892, Prodh2, proline dehydrogenase (oxidase) 2, [Score=186, Expect=1e-52]} {Dmel: FBgn0003423, slgA, sluggish A, [Score=158, Expect=2e-43]} {Celegans: WBGene00007197, B0513.5, Proline dehydrogenase 1, mitochondrial, [Score=136, Expect=2e-34]} {Smed: dd_Smed_v6_7017_0_1, dd_Smed_v6_7017_0_1, [Score=129, Expect=9e-32]} {RNA1509_11820, RNA1509_13948, RNA1509_51566} {RNA1310_17498, RNA1509_11820, RNA1509_13948, RNA1509_51566} {RNA1509_11820, RNA1509_13948, RNA1509_51566, RNA815_31494} |
4. | MligTC455_02977 | 9 | 0.19 | Mlig455_030233, Mlig455_068012 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_030233 {REF} {Length: 1705} {Pfam: Glycine rich protein [PF12810.9, score=28.6]} {RNA1310_95913} Mlig455_068012 {REF} {Length: 1348} {Pfam: Glycine rich protein [PF12810.9, score=29.2]} {RNA1310_95913} |
|
5. | MligTC455_18043 | 7 | 0.15 | Mlig455_057278 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_057278 {REF} {Length: 635} {NoTransDecoderORF} {RNA1509_36910} {RNA1310_134608} | |
6. | MligTC455_39819 | 11 | 0.24 | Mlig455_020402 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_020402 {REF} {Length: 1516} | |
7. | MligTC455_13206 | 10 | 0.2 | Mlig455_018601, Mlig455_018615 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_018601 {REF} {Length: 1042} {NoTransDecoderORF} {RNA1310_100887} Mlig455_018615 {REF} {Length: 1012} {NoTransDecoderORF} {RNA1310_100887} |
|
8. | MligTC455_14568 | 4 | 0.07 | Mlig455_026076 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_026076 {REF} {Length: 794} {NoTransDecoderORF} {RNA1310_55322} | |
9. | MligTC455_16042 | 45 | 0.95 | Mlig455_000892 | Neo: - Age: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_000892 {REF} {Length: 487} {NoTransDecoderORF} {RNA1310_142782} | |
10. | MligTC455_37112 | 144 | 3 | Mlig455_011711 | Neo: - Age: - |
NEUROG1 | 0.99 | - | - | - | - | 0.990 | - | Mlig455_011711 {REF} {Length: 2595} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=56.3]} {Human: ENSG00000181965, NEUROG1, neurogenin 1, [RH, Score=82.8, Expect=5e-19]; ENSG00000178403, NEUROG2, neurogenin 2, [RH, Score=79.7, Expect=1e-17]} {Mouse: ENSMUSG00000048904, Neurog1, neurogenin 1, [RH, Score=82.0, Expect=7e-19]; ENSMUSG00000027967, Neurog2, neurogenin 2, [RH, Score=80.1, Expect=6e-18]} {Dmel: FBgn0015550, tap, target of Poxn, [RH, Score=85.5, Expect=2e-19]} {Celegans: WBGene00003595, ngn-1, NeuroGeNin, [RH, Score=70.1, Expect=5e-15]} {Smed: dd_Smed_v6_21717_0_1, dd_Smed_v6_21717_0_1, [Score=68.2, Expect=3e-14]} {RNA1509_25288} {RNA1310_19679} {RNA815_8549.1} |
11. | MligTC455_56577 | 6 | 0.12 | Mlig455_044646 | Neo: - Age: - |
0.99 | - | - | - | - | 0.990 | - | Mlig455_044646 {REF} {Length: 383} {RNA1310_116667} | |
12. | MligTC455_13973 | 6 | 0.13 | Mlig455_062040 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_062040 {REF} {Length: 634} {NoTransDecoderORF} {RNA1509_47371} | |
13. | MligTC455_14143 | 12 | 0.25 | Mlig455_013538 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_013538 {REF} {Length: 951} {NoTransDecoderORF} {RNA1509_26163} {RNA1310_103321} {RNA815_47548} | |
14. | MligTC455_32102 | 22 | 0.45 | Mlig455_036933 | Neo: - Age: Up-Down-Down |
0.988 | - | - | - | - | 0.988 | - | Mlig455_036933 {REF} {Length: 2307} {RNA1509_41399} {RNA1310_15329} {RNA815_6647} | |
15. | MligTC455_52002 | 18 | 0.37 | Mlig455_015922 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_015922 {REF} {Length: 3702} {RNA1310_60405} {RNA815_40963} | |
16. | MligTC455_13770 | 27 | 0.56 | Mlig455_033395 | Neo: - Age: - |
HYOU1 | 0.987 | - | - | - | - | 0.987 | - | Mlig455_033395 {REF} {Length: 4373} {Pfam: Hsp70 protein [PF00012.22, score=125.6]} {Human: ENSG00000280682, HYOU1, hypoxia up-regulated 1, [Score=207, Expect=2e-55]; ENSG00000149428, HYOU1, hypoxia up-regulated 1, [Score=207, Expect=2e-55]} {Mouse: ENSMUSG00000032115, Hyou1, hypoxia up-regulated 1, [Score=214, Expect=7e-58]} {Dmel: FBgn0023529, CG2918, [Score=213, Expect=8e-58]} {Celegans: WBGene00020781, T24H7.2, [Score=174, Expect=4e-45]} {Smed: dd_Smed_v6_2324_0_1, dd_Smed_v6_2324_0_1, [Score=213, Expect=7e-58]} {RNA1509_59725} {RNA1310_10861.1} {RNA815_31861.2} |
17. | MligTC455_18711 | 23 | 0.48 | Mlig455_025487, Mlig455_025509, Mlig455_070529 | Neo: - Age: - |
0.987 | - | - | - | - | 0.987 | - | Mlig455_025487 {REF} {Length: 2041} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=26.7]} {RNA1509_40708} {RNA1310_26224} {RNA815_14744.1} Mlig455_025509 {REF} {Length: 1175} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=26.7]} {RNA1509_40708} {RNA1310_26224} {RNA815_14744.1} Mlig455_070529 {REF} {Length: 819} {RNA1509_42280} {RNA1310_22730} {RNA815_32971} |
|
18. | MligTC455_20324 | 12 | 0.24 | Mlig455_022502 | Neo: - Age: - |
0.987 | - | - | - | - | - | 0.987 | Mlig455_022502 {REF} {Length: 1073} {NoTransDecoderORF} {RNA1310_74877} {RNA815_44278} | |
19. | MligTC455_17645 | 48 | 1 | Mlig455_008070 | Neo: - |
0.984 | - | - | - | - | 0.984 | - | Mlig455_008070 {REF} {Length: 1924} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} | |
20. | MligTC455_22689 | 26 | 0.54 | Mlig455_050479 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_050479 {REF} {Length: 4332} {RNA1310_123601} {RNA815_61258} | |
21. | MligTC455_35508 | 4 | 0.08 | Mlig455_063686 | Neo: - Age: - |
HRH2 | 0.983 | - | - | - | - | 0.983 | - | Mlig455_063686 {REF} {Length: 884} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=70.8]} {Human: ENSG00000113749, HRH2, histamine receptor H2, [Score=67.4, Expect=5e-12]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=62.4, Expect=1e-10]; ENSMUSG00000037424, Taar9, trace amine-associated receptor 9, [Score=62.0, Expect=2e-10]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [Score=50.1, Expect=6e-07]} |
22. | MligTC455_09723 | 43 | 0.89 | Mlig455_048052, Mlig455_048071 | Neo: - Age: Up-Down-Down |
0.981 | - | - | - | - | 0.981 | - | Mlig455_048052 {REF} {Length: 3592} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=110.8]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.6]; Glycine rich protein family [PF07172.13, score=21.2]} {Dmel: FBgn0033579, CG13229, [Score=121, Expect=1e-29]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=135, Expect=2e-34]} {Smed: dd_Smed_v6_24203_0_1, dd_Smed_v6_24203_0_1, [Score=204, Expect=1e-60]} {RNA1509_18576} {RNA1310_81440} {RNA815_16348} Mlig455_048071 {REF} {Length: 4002} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=110.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=58.2]; Glycine rich protein family [PF07172.13, score=21.9]} {Dmel: FBgn0033579, CG13229, [Score=119, Expect=5e-29]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=131, Expect=4e-33]} {Smed: dd_Smed_v6_24203_0_1, dd_Smed_v6_24203_0_1, [Score=202, Expect=8e-60]} {RNA1509_18576} {RNA1310_81440} {RNA815_16348} |
|
23. | MligTC455_09870 | 8 | 0.17 | Mlig455_053392 | Neo: - Age: - |
0.981 | - | - | - | - | 0.981 | - | Mlig455_053392 {REF} {Length: 338} {NoTransDecoderORF} {RNA1310_87210} | |
24. | MligTC455_08714 | 6 | 0.12 | Mlig455_012167 | Neo: - Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_012167 {REF} {Length: 312} {NoTransDecoderORF} {RNA1509_29268} {RNA1310_107364} {RNA815_51387} | |
25. | MligTC455_10770 | 9 | 0.19 | Mlig455_069191 | Neo: - Age: - |
NEFM | 0.98 | - | - | - | - | 0.980 | - | Mlig455_069191 {REF} {Length: 2284} {Human: ENSG00000104722, NEFM, neurofilament medium, [Score=50.8, Expect=6e-06]} |
26. | MligTC455_26508 | 9 | 0.19 | Mlig455_004141, Mlig455_006847, Mlig455_042467, Mlig455_045362, Mlig455_055144, Mlig455_056120 | Neo: Germline Age: logFC(26M/2M)=-0.588 |
CELSR2, RTL1 | 0.98 | - | - | - | - | 0.980 | - | Mlig455_004141 {REF} {Length: 4731} {Pfam: Cadherin domain [PF00028.19, score=27.7]} {Human: ENSG00000143126, CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, [Score=63.9, Expect=6e-11]; ENSG00000165323, FAT3, FAT atypical cadherin 3, [Score=61.2, Expect=5e-10]; ENSG00000282908, FAT3, FAT atypical cadherin 3, [Score=61.2, Expect=5e-10]} {Mouse: ENSMUSG00000068740, Celsr2, cadherin, EGF LAG seven-pass G-type receptor 2, [Score=63.9, Expect=3e-11]; ENSMUSG00000074505, Fat3, FAT atypical cadherin 3, [Score=61.6, Expect=2e-10]} {Dmel: FBgn0024836, stan, starry night, [Score=59.7, Expect=6e-10]} {Smed: dd_Smed_v6_15643_0_1, dd_Smed_v6_15643_0_1, [Score=53.9, Expect=3e-08]} {RNA1509_50918} {RNA1310_2131.1} {RNA815_11127} Mlig455_006847 {REF} {Length: 4706} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=114.8]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=105.5]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=60.3]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=93.2, Expect=2e-18]} {Smed: dd_Smed_v6_1574_6_43, dd_Smed_v6_1574_6_43, [Score=232, Expect=6e-66]} {RNA1509_50918} {RNA1310_2131.1} {RNA815_11127} Mlig455_042467 {REF} {Length: 3160} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=60.6]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=80.1, Expect=1e-14]} {Smed: dd_Smed_v6_1574_6_44, dd_Smed_v6_1574_6_44, [Score=179, Expect=4e-48]} {RNA1509_50918} {RNA1310_2131.1} {RNA815_11127} Mlig455_045362 {REF} {Length: 4361} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=58.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=19.9]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=157, Expect=5e-40]} {RNA1509_50918} {RNA1310_2131.1} {RNA815_11127} Mlig455_055144 {REF} {Length: 4897} {Pfam: RNase H-like domain found in reverse transcriptase [PF17917.3, score=114.8]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=105.5]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=56.4]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=92.0, Expect=3e-18]} {Smed: dd_Smed_v6_1574_6_44, dd_Smed_v6_1574_6_44, [Score=227, Expect=3e-64]} {RNA1509_50918} {RNA1310_2131.1} {RNA815_11127} Mlig455_056120 {REF} {Length: 321} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=23.6]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=68.6, Expect=8e-15]} {RNA1509_50918} {RNA1310_2131.1} |
27. | MligTC455_11835 | 209 | 4.36 | Mlig455_003368 | Neo: Germline Age: - Region-specific R4: 4.850 Region-enriched R4: 2.315/0.00720 |
SLC26A6 | 0.979 | - | - | - | 0.979 | - | - | Mlig455_003368 {REF} {Length: 2320} {Pfam: STAS domain [PF01740.23, score=23.2]} {Human: ENSG00000225697, SLC26A6, solute carrier family 26 member 6, [Score=51.2, Expect=1e-08]} {Mouse: ENSMUSG00000023259, Slc26a6, solute carrier family 26, member 6, [Score=56.2, Expect=1e-10]; ENSMUSG00000107138, Slc26a6, solute carrier family 26, member 6, [Score=56.2, Expect=1e-10]} {Smed: dd_Smed_v6_8150_0_1, dd_Smed_v6_8150_0_1, [Score=52.8, Expect=9e-10]} {RNA1509_19433} {RNA1310_10499} {RNA815_36330} |
28. | MligTC455_52111 | 120 | 2.5 | Mlig455_036893 | Neo: - Age: - Region-enriched R5: 2.209/0.02779 |
0.976 | - | - | - | - | 0.976 | - | Mlig455_036893 {REF} {Length: 1778} {RNA1310_41662.1} {RNA815_33206} | |
29. | MligTC455_00203 | 3 | 0.06 | Mlig455_051710 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_051710 {REF} {Length: 302} {NoTransDecoderORF} | |
30. | MligTC455_11330 | 17 | 0.35 | Mlig455_030268 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_030268 {REF} {Length: 2941} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.8]} {RNA1509_30357} {RNA1310_28164} {RNA815_12945.1} | |
31. | MligTC455_11764 | 3 | 0.05 | Mlig455_038701 | Neo: - Age: - |
ASIC5 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_038701 {REF} {Length: 2030} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=188.7]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=64.3, Expect=3e-10]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=64.7, Expect=2e-10]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=63.2, Expect=6e-10]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=77.8, Expect=7e-15]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=105, Expect=8e-24]} {RNA1310_63403} {RNA815_41862} |
32. | MligTC455_13276 | 3 | 0.06 | Mlig455_023464 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_023464 {REF} {Length: 339} {NoTransDecoderORF} {RNA1310_137491} | |
33. | MligTC455_57301 | 6 | 0.13 | Mlig455_045739 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_045739 {REF} {Length: 397} {NoTransDecoderORF} {RNA1310_134600} | |
34. | MligTC455_22054 | 7 | 0.14 | Mlig455_019642 | Neo: - Age: - |
IGFN1 | 0.972 | - | - | - | - | 0.972 | - | Mlig455_019642 {REF} {Length: 1018} {Human: ENSG00000163395, IGFN1, immunoglobulin-like and fibronectin type III domain containing 1, [Score=50.1, Expect=1e-07]} {RNA1509_39632} {RNA1310_35459.1} {RNA815_40343} |
35. | MligTC455_32328 | 43 | 0.89 | Mlig455_046579 | Neo: - Age: Down-Up-Down |
TRIM9 | 0.972 | - | - | - | - | 0.972 | - | Mlig455_046579 {REF} {Length: 5213} {Pfam: SPRY domain [PF00622.30, score=46.9]; B-box zinc finger [PF00643.26, score=29.5]; zinc finger of C3HC4-type, RING [PF15227.8, score=24.6]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=24.4]; RING-type zinc-finger [PF13445.8, score=21.9]; Fibronectin type III domain [PF00041.23, score=21.0]; Tc5 transposase DNA-binding domain [PF03221.18, score=20.1]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=18.9]} {Human: ENSG00000100505, TRIM9, tripartite motif containing 9, [Score=476, Expect=2e-151]} {Mouse: ENSMUSG00000021071, Trim9, tripartite motif-containing 9, [Score=476, Expect=2e-151]} {Dmel: FBgn0051721, Trim9, Tripartite motif containing 9, [Score=446, Expect=7e-140]} {Celegans: WBGene00016539, madd-2, [Score=410, Expect=2e-126]} {Smed: dd_Smed_v6_8386_0_1, dd_Smed_v6_8386_0_1, [Score=530, Expect=7e-172]} {RNA1509_37451} {RNA1310_8634.1} {RNA815_9833} |
36. | MligTC455_42606 | 587 | 12.23 | Mlig455_028247 | Neo: - Age: - Region-enriched R7: 3.014/0.00027 |
0.971 | - | - | - | - | 0.971 | - | Mlig455_028247 {REF} {Length: 1418} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=84.5]} {RNA1509_19563, RNA1509_30809, RNA1509_35935} {RNA1310_42765.2, RNA1509_19563, RNA1509_30809, RNA1509_35935} {RNA1509_19563, RNA1509_30809, RNA1509_35935, RNA815_22214} | |
37. | MligTC455_00365 | 18 | 0.37 | Mlig455_030202 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_030202 {REF} {Length: 397} {NoTransDecoderORF} {RNA1310_64969} | |
38. | MligTC455_13560 | 17 | 0.35 | Mlig455_009866 | Neo: - Age: - |
PCDH11Y | 0.97 | - | - | - | - | 0.970 | - | Mlig455_009866 {REF} {Length: 3451} {Pfam: Cadherin domain [PF00028.19, score=95.6]} {Human: ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=105, Expect=3e-23]; ENSG00000253873, PCDHGA11, protocadherin gamma subfamily A, 11, [Score=103, Expect=1e-22]; ENSG00000184226, PCDH9, protocadherin 9, [Score=102, Expect=4e-22]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=101, Expect=5e-22]; ENSG00000081853, PCDHGA2, protocadherin gamma subfamily A, 2, [Score=100, Expect=7e-22]; ENSG00000156453, PCDH1, protocadherin 1, [Score=100, Expect=9e-22]; ENSG00000083857, FAT1, FAT atypical cadherin 1, [Score=99.8, Expect=3e-21]} {Mouse: ENSMUSG00000103472, Pcdhga7, protocadherin gamma subfamily A, 7, [Score=108, Expect=1e-24]; ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=105, Expect=3e-23]; ENSMUSG00000103332, Pcdhga2, protocadherin gamma subfamily A, 2, [Score=105, Expect=2e-23]; ENSMUSG00000070047, Fat1, FAT atypical cadherin 1, [Score=105, Expect=3e-23]; ENSMUSG00000102543, Pcdhgc5, protocadherin gamma subfamily C, 5, [Score=104, Expect=4e-23]; ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=103, Expect=9e-23]} {Dmel: FBgn0001075, ft, fat, [Score=93.6, Expect=1e-19]} {Celegans: WBGene00019994, cdh-1, CaDHerin family, [Score=70.5, Expect=2e-12]} {Smed: dd_Smed_v6_17019_0_1, dd_Smed_v6_17019_0_1, [Score=103, Expect=5e-23]} {RNA1509_2412} {RNA1310_104220} {RNA815_16323} |
39. | MligTC455_37619 | 6 | 0.12 | Mlig455_007783, Mlig455_031138, Mlig455_056632 | Neo: - Age: - |
STOM | 0.97 | - | - | - | - | 0.970 | - | Mlig455_007783 {REF} {Length: 733} {NoTransDecoderORF} Mlig455_031138 {REF} {Length: 839} {Human: ENSG00000148175, STOM, stomatin, [Score=81.3, Expect=2e-18]} {Mouse: ENSMUSG00000026880, Stom, stomatin, [Score=75.9, Expect=1e-16]; ENSMUSG00000026602, Nphs2, nephrosis 2, podocin, [Score=72.8, Expect=3e-15]} {Dmel: FBgn0260657, CG42540, [Score=81.3, Expect=2e-18]} {Celegans: WBGene00006068, sto-6, STOmatin, [Score=90.1, Expect=4e-22]} {Smed: dd_Smed_v6_11883_0_1, dd_Smed_v6_11883_0_1, [Score=80.1, Expect=2e-19]} {RNA1310_23238} {RNA815_24338} Mlig455_056632 {REF} {Length: 710} |
40. | MligTC455_42067 | 11 | 0.24 | Mlig455_011212 | Neo: - Age: - |
GNAL | 0.969 | - | - | - | - | 0.969 | - | Mlig455_011212 {REF} {Length: 3259} {Pfam: G-protein alpha subunit [PF00503.22, score=322.4]; ADP-ribosylation factor family [PF00025.23, score=60.0]; Gtr1/RagA G protein conserved region [PF04670.14, score=24.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=21.5]} {Human: ENSG00000141404, GNAL, G protein subunit alpha L, [Score=499, Expect=7e-178]; ENSG00000087460, GNAS, GNAS complex locus, [Score=490, Expect=4e-174]} {Mouse: ENSMUSG00000024524, Gnal, guanine nucleotide binding protein, alpha stimulating, olfactory type, [Score=498, Expect=1e-177]; ENSMUSG00000027523, Gnas, GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus, [Score=488, Expect=1e-173]} {Dmel: FBgn0001123, Galphas, G protein alpha s subunit, [Score=504, Expect=7e-180]} {Celegans: WBGene00001745, gsa-1, G protein, Subunit Alpha, [Score=454, Expect=2e-160]} {Smed: dd_Smed_v6_6167_0_1, dd_Smed_v6_6167_0_1, [Score=509, Expect=0.0]} {RNA1509_11968} {RNA1310_15496} {RNA815_8201} |
41. | MligTC455_12687 | 7 | 0.15 | Mlig455_016746, Mlig455_016758 | Neo: - Age: Up-Down-Up |
CACNA1C, CACNA1D | 0.967 | - | - | - | - | 0.967 | - | Mlig455_016746 {REF} {Length: 8806} {Pfam: Ion transport protein [PF00520.33, score=816.5]; Voltage gated calcium channel IQ domain [PF08763.13, score=101.9]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=91.0]; Polycystin cation channel [PF08016.14, score=23.2]; Protein trafficking PGA2 [PF07543.14, score=19.7]} {Human: ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [RH, Score=1801, Expect=0.0]; ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [RH, Score=1801, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [RH, Score=1757, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [RH, Score=1723, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [RH, Score=1806, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [RH, Score=1753, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [RH, Score=1718, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [RH, Score=1899, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [RH, Score=1809, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_27, dd_Smed_v6_8899_0_27, [RH, Score=1934, Expect=0.0]} {RNA1509_7565} {RNA1310_546.1} {RNA815_3074} Mlig455_016758 {REF} {Length: 716} {Human: ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=52.4, Expect=3e-07]} {Mouse: ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=50.1, Expect=1e-06]} {RNA1509_7565} {RNA1310_1492.2} {RNA815_11990} |
42. | MligTC455_03139 | 8 | 0.16 | Mlig455_039544 | Neo: - Age: - |
PRR9 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_039544 {REF} {Length: 646} {Human: ENSG00000203783, PRR9, proline rich 9, [Score=48.5, Expect=2e-07]} |
43. | MligTC455_13424 | 708 | 14.75 | Mlig455_044367 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.089 Region-enriched R7: 4.024/0.00101 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_044367 {REF} {Length: 633} {RNA1509_34081, RNA1509_52094} {RNA1310_75122.1, RNA1509_34081, RNA1509_52094} {RNA1509_34081, RNA1509_52094, RNA815_57840} | |
44. | MligTC455_43515 | 37 | 0.76 | Mlig455_028938 | Neo: - Age: - Region-enriched R4: 5.640/0.02017 |
0.965 | - | - | - | - | 0.965 | - | Mlig455_028938 {REF} {Length: 2469} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_41781} {RNA815_21314} | |
45. | MligTC455_12729 | 17 | 0.35 | Mlig455_059868 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_059868 {REF} {Length: 655} {NoTransDecoderORF} {RNA1509_32319} {RNA1310_13107.1} {RNA815_39540} | |
46. | MligTC455_42887 | 60 | 1.24 | Mlig455_036468, Mlig455_056252 | Neo: - Age: - |
CCKAR | 0.963 | - | - | - | - | 0.963 | - | Mlig455_036468 {REF} {Length: 2390} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=81.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=37.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=19.5]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=53.5, Expect=5e-07]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=53.1, Expect=4e-07]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [Score=59.3, Expect=4e-09]} {Dmel: FBgn0264002, MsR2, Myosuppressin receptor 2, [Score=57.0, Expect=3e-08]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=68.6, Expect=3e-12]} {Smed: dd_Smed_v6_9550_0_1, dd_Smed_v6_9550_0_1, [Score=69.7, Expect=9e-13]} {RNA1310_37299} {RNA815_29990} Mlig455_056252 {REF} {Length: 2265} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.8]} {RNA1310_56612} {RNA815_44133} |
47. | MligTC455_03769 | 5 | 0.11 | Mlig455_047699 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_047699 {REF} {Length: 589} {Pfam: WSC domain [PF01822.21, score=55.2]; PAN domain [PF00024.28, score=21.7]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1509_29094} {RNA1310_42587} {RNA815_27950.1} | |
48. | MligTC455_36556 | 37 | 0.78 | Mlig455_006952 | Neo: - Age: - Region-enriched R4: 4.369/0.00522 |
0.962 | - | - | - | 0.962 | - | - | Mlig455_006952 {REF} {Length: 3049} {Pfam: CD80-like C2-set immunoglobulin domain [PF08205.14, score=18.6]} {RNA1509_41400} {RNA1310_13831} {RNA815_3928} | |
49. | MligTC455_50049 | 291 | 6.06 | Mlig455_030763 | Neo: Germline Age: Up-Down-Down Region-specific R4: 5.826 Region-enriched R4: 3.092/0.00052 |
RAB12 | 0.962 | - | - | - | 0.962 | - | - | Mlig455_030763 {REF} {Length: 1725} {Pfam: Ras family [PF00071.24, score=58.1]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=57.3]; 50S ribosome-binding GTPase [PF01926.25, score=21.3]; ADP-ribosylation factor family [PF00025.23, score=20.6]} {Human: ENSG00000206418, RAB12, RAB12, member RAS oncogene family, [Score=61.6, Expect=3e-10]; ENSG00000267261, AC099811.2, novel protein, [Score=59.7, Expect=8e-10]} {Mouse: ENSMUSG00000023460, Rab12, RAB12, member RAS oncogene family, [Score=59.3, Expect=8e-10]; ENSMUSG00000019173, Rab5c, RAB5C, member RAS oncogene family, [Score=57.0, Expect=3e-09]} {Dmel: FBgn0015797, Rab6, [Score=61.2, Expect=6e-11]} {Celegans: WBGene00004281, rab-28, RAB family, [Score=65.5, Expect=2e-12]} {Smed: dd_Smed_v6_3370_0_1, dd_Smed_v6_3370_0_1, [Score=70.1, Expect=3e-14]} {RNA1509_18190} {RNA1310_18285} {RNA815_6420} |
50. | MligTC455_09385 | 5 | 0.11 | Mlig455_022564 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_022564 {REF} {Length: 1192} {NoTransDecoderORF} {RNA1509_35668} {RNA1310_23997.1} {RNA815_18824.1} | |
51. | MligTC455_40018 | 295 | 6.15 | Mlig455_037646, Mlig455_069914 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.048 Region-enriched R8: 4.445/0.00001 |
AC243734.1, CHRNA2 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_037646 {REF} {Length: 2101} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=46.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=27.0]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=68.9, Expect=6e-12]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=65.5, Expect=8e-11]} {Mouse: ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=75.5, Expect=3e-14]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=73.2, Expect=2e-13]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=82.8, Expect=9e-17]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=71.2, Expect=4e-13]} {Smed: dd_Smed_v6_8486_0_1, dd_Smed_v6_8486_0_1, [Score=78.2, Expect=2e-15]} {RNA1509_50033} {RNA1310_22440} {RNA815_15508} Mlig455_069914 {REF} {Length: 3748} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=68.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=60.3]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=108, Expect=5e-25]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=108, Expect=9e-25]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=108, Expect=5e-25]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=107, Expect=1e-24]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=99.4, Expect=5e-22]} {Celegans: WBGene00000951, deg-3, Acetylcholine receptor subunit alpha-type deg-3, [Score=94.0, Expect=3e-20]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=113, Expect=7e-27]} {RNA1509_50033} {RNA1310_16096, RNA1509_50033} {RNA1509_50033, RNA815_15508} |
52. | MligTC455_17825 | 26 | 0.54 | Mlig455_041647 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_041647 {REF} {Length: 2713} {NoTransDecoderORF} {RNA1310_83449} {RNA815_41475} | |
53. | MligTC455_21038 | 10 | 0.22 | Mlig455_026297, Mlig455_052713 | Neo: - Age: - |
GLRA2 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_026297 {REF} {Length: 3375} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=137.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=102.8]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=259, Expect=5e-80]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=258, Expect=2e-79]; ENSG00000109738, GLRB, glycine receptor beta, [Score=257, Expect=1e-78]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=253, Expect=4e-78]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=5e-76]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=259, Expect=6e-80]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=253, Expect=3e-77]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=253, Expect=1e-77]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=250, Expect=4e-76]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=8e-76]} {Dmel: FBgn0024963, GluClalpha, [Score=245, Expect=6e-75]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [Score=241, Expect=2e-73]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=280, Expect=1e-88]} {RNA1310_99355} Mlig455_052713 {REF} {Length: 1407} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=139.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=78.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=259, Expect=3e-82]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=253, Expect=5e-80]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=252, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=2e-78]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=258, Expect=4e-82]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=253, Expect=5e-80]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=252, Expect=2e-79]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-78]} {Dmel: FBgn0024963, GluClalpha, [Score=238, Expect=5e-76]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [Score=238, Expect=2e-74]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=275, Expect=4e-89]} {RNA1310_135132} |
54. | MligTC455_34140 | 16 | 0.33 | Mlig455_058309 | Neo: - Age: Down-Down-Down |
ATP11C | 0.96 | - | - | - | - | 0.960 | - | Mlig455_058309 {REF} {Length: 2295} {TRANSSPLICED} {Pfam: Phospholipid-translocating ATPase N-terminal [PF16209.7, score=73.8]; Cation transport ATPase (P-type) [PF13246.8, score=47.4]; E1-E2 ATPase [PF00122.22, score=42.0]; haloacid dehalogenase-like hydrolase [PF00702.28, score=32.0]} {Human: ENSG00000101974, ATP11C, ATPase phospholipid transporting 11C, [Score=283, Expect=1e-82]; ENSG00000058063, ATP11B, ATPase phospholipid transporting 11B (putative), [Score=278, Expect=6e-81]; ENSG00000068650, ATP11A, ATPase phospholipid transporting 11A, [Score=270, Expect=3e-78]} {Mouse: ENSMUSG00000062949, Atp11c, ATPase, class VI, type 11C, [Score=276, Expect=2e-80]; ENSMUSG00000108408, Atp11c, ATPase, class VI, type 11C, [Score=276, Expect=2e-80]; ENSMUSG00000031441, Atp11a, ATPase, class VI, type 11A, [Score=273, Expect=5e-79]; ENSMUSG00000037400, Atp11b, ATPase, class VI, type 11B, [Score=269, Expect=1e-77]} {Dmel: FBgn0030747, CG4301, [Score=227, Expect=3e-63]} {Celegans: WBGene00019166, tat-2, Phospholipid-transporting ATPase, [Score=182, Expect=4e-48]} {Smed: dd_Smed_v6_5121_0_1, dd_Smed_v6_5121_0_1, [Score=281, Expect=2e-82]} {RNA1509_4285} {RNA1310_2328.3} {RNA815_702} |
55. | MligTC455_49279 | 30 | 0.61 | Mlig455_043109 | Neo: - Age: - |
TRPC4 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_043109 {REF} {Length: 1771} {Human: ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [Score=175, Expect=1e-48]} {Mouse: ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [Score=176, Expect=3e-49]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=204, Expect=8e-59]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [Score=133, Expect=2e-34]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [Score=258, Expect=8e-79]} {RNA1509_34138} {RNA1310_16811.1} {RNA815_23789} |
56. | MligTC455_22098 | 31 | 0.66 | Mlig455_004396, Mlig455_037219 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_004396 {REF} {Length: 1521} {RNA1310_40784} Mlig455_037219 {REF} {Length: 1583} {RNA1310_63625} |
|
57. | MligTC455_08229 | 4 | 0.08 | Mlig455_041581 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_041581 {REF} {Length: 305} {NoTransDecoderORF} {tRNA: Trp(CCA), score=71.2} | |
58. | MligTC455_07889 | 13 | 0.28 | Mlig455_056852 | Neo: - Age: - |
GRIA4 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_056852 {REF} {Length: 2815} {Pfam: Ligand-gated ion channel [PF00060.28, score=65.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=38.1]} {Human: ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=113, Expect=5e-25]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=111, Expect=1e-24]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=109, Expect=9e-24]} {Mouse: ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=114, Expect=2e-25]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=111, Expect=1e-24]} {Dmel: FBgn0051201, GluRIIE, Glutamate receptor IIE, [Score=102, Expect=6e-22]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=105, Expect=4e-23]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=232, Expect=3e-68]} |
59. | MligTC455_18456 | 1096 | 22.84 | Mlig455_025389 | Neo: - Age: Down-Down-Up Region-enriched R6: 6.958/0.00000 |
0.953 | - | - | - | - | 0.953 | - | Mlig455_025389 {REF} {Length: 781} {RNA1509_31308, RNA1509_36358, RNA1509_37939} {RNA1310_53601, RNA1509_31308, RNA1509_36358, RNA1509_37939} {RNA1509_31308, RNA1509_36358, RNA1509_37939, RNA815_21102} | |
60. | MligTC455_20743 | 385 | 8.02 | Mlig455_030435 | Neo: - Age: Down-Up-Down |
TNIK | 0.953 | - | - | - | - | 0.953 | - | Mlig455_030435 {REF} {Length: 6454} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=210.4]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=157.0]; ABC1 atypical kinase-like domain [PF03109.18, score=34.0]; CNH domain [PF00780.24, score=31.8]; Fungal protein kinase [PF17667.3, score=23.2]} {Human: ENSG00000154310, TNIK, TRAF2 and NCK interacting kinase, [RH, Score=504, Expect=2e-159]; ENSG00000141503, MINK1, misshapen like kinase 1, [RH, Score=482, Expect=8e-152]} {Mouse: ENSMUSG00000027692, Tnik, TRAF2 and NCK interacting kinase, [RH, Score=504, Expect=2e-160]; ENSMUSG00000020827, Mink1, misshapen-like kinase 1 (zebrafish), [RH, Score=483, Expect=3e-152]} {Dmel: FBgn0010909, msn, misshapen, [RH, Score=509, Expect=8e-161]} {Celegans: WBGene00003247, mig-15, Serine/threonine-protein kinase mig-15, [RH, Score=505, Expect=4e-163]} {Smed: dd_Smed_v6_1029_0_1, dd_Smed_v6_1029_0_1, [RH, Score=446, Expect=6e-142]} {RNA1509_35146, RNA1509_5951} {RNA1310_3546, RNA1509_35146, RNA1509_5951} {RNA1509_35146, RNA1509_5951, RNA815_6714} |
61. | MligTC455_39564 | 19 | 0.4 | Mlig455_068296 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_068296 {REF} {Length: 2744} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=44.3]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=87.8, Expect=1e-19]} {RNA1509_47233} {RNA1310_38022} {RNA815_22291} | |
62. | MligTC455_42010 | 89 | 1.85 | Mlig455_040323 | Neo: - Age: Up-Down-Down |
SEC23IP | 0.951 | - | - | - | - | 0.951 | - | Mlig455_040323 {REF} {Length: 3149} {TRANSSPLICED} {Pfam: DDHD domain [PF02862.19, score=163.9]; SAM domain (Sterile alpha motif) [PF00536.32, score=29.1]; SAM domain (Sterile alpha motif) [PF07647.19, score=21.0]; WWE domain [PF02825.22, score=20.1]} {Human: ENSG00000107651, SEC23IP, SEC23 interacting protein, [RH, Score=489, Expect=7e-159]; ENSG00000085788, DDHD2, DDHD domain containing 2, [RH, Score=476, Expect=2e-157]} {Mouse: ENSMUSG00000055319, Sec23ip, Sec23 interacting protein, [RH, Score=492, Expect=2e-160]; ENSMUSG00000061313, Ddhd2, DDHD domain containing 2, [RH, Score=470, Expect=2e-155]} {Dmel: FBgn0031990, PAPLA1, Phosphatidic Acid Phospholipase A1, [RH, Score=258, Expect=2e-75]} {Celegans: WBGene00019747, ipla-1, Intracelllar PhosphoLipase A family; Intracellular phospholipase A1, [Score=97.4, Expect=1e-20]} {Smed: dd_Smed_v6_4014_0_1, dd_Smed_v6_4014_0_1, [RH, Score=287, Expect=9e-83]} {RNA1509_38825} {RNA1310_9070.1} {RNA815_7099} |
63. | MligTC455_43829 | 45 | 0.95 | Mlig455_008872, Mlig455_008973 | Neo: - Age: Down-Up-Up |
TLL1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_008872 {REF} {Length: 3395} {Pfam: CUB domain [PF00431.22, score=147.6]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=92.8, Expect=1e-18]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=91.3, Expect=3e-18]} {Dmel: FBgn0261262, CG42613, [Score=102, Expect=9e-22]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=79.0, Expect=9e-15]} {Smed: dd_Smed_v6_19493_0_1, dd_Smed_v6_19493_0_1, [Score=265, Expect=1e-76]} {RNA1509_49507} {RNA1310_6026} {RNA815_27015} Mlig455_008973 {REF} {Length: 2985} {Pfam: CUB domain [PF00431.22, score=149.2]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=90.5, Expect=7e-18]; ENSG00000107611, CUBN, cubilin, [Score=86.3, Expect=2e-16]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=89.0, Expect=2e-17]} {Dmel: FBgn0261262, CG42613, [Score=101, Expect=1e-21]} {Celegans: WBGene00002977, lev-10, LEV-10B, [Score=81.6, Expect=1e-15]} {Smed: dd_Smed_v6_19493_0_1, dd_Smed_v6_19493_0_1, [Score=267, Expect=2e-77]} {RNA1509_49507, RNA1509_572} {RNA1310_6026, RNA1509_49507, RNA1509_572} {RNA1509_49507, RNA1509_572, RNA815_27015} |
64. | MligTC455_17666 | 155 | 3.23 | Mlig455_024776, Mlig455_066107, Mlig455_068666 | Neo: - Age: - |
SYDE2 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_024776 {REF} {Length: 4128} {Pfam: RhoGAP domain [PF00620.29, score=133.7]; Pentapeptide repeats (9 copies) [PF13599.8, score=93.3]; Pentapeptide repeats (8 copies) [PF00805.24, score=91.0]; Choristoneura fumiferana antifreeze protein (CfAFP) [PF05264.13, score=19.3]} {Human: ENSG00000097096, SYDE2, synapse defective Rho GTPase homolog 2, [RH, Score=240, Expect=7e-65]} {Mouse: ENSMUSG00000036863, Syde2, synapse defective 1, Rho GTPase, homolog 2 (C. elegans), [RH, Score=236, Expect=2e-63]} {Dmel: FBgn0039883, RhoGAP100F, Rho GTPase activating protein at 100F, [RH, Score=288, Expect=2e-80]} {Celegans: WBGene00006363, syd-1, Rho GTPase-activating protein syd-1, [RH, Score=211, Expect=4e-56]} {Smed: dd_Smed_v6_12363_0_1, dd_Smed_v6_12363_0_1, [RH, Score=412, Expect=5e-125]} {RNA1509_36084} {RNA1310_10433} {RNA815_13685} Mlig455_066107 {REF} {Length: 3249} {Pfam: RhoGAP domain [PF00620.29, score=134.1]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=20.1]; Protein of unknown function (DUF2722) [PF10846.10, score=18.6]} {Human: ENSG00000097096, SYDE2, synapse defective Rho GTPase homolog 2, [RH, Score=233, Expect=3e-64]} {Mouse: ENSMUSG00000036863, Syde2, synapse defective 1, Rho GTPase, homolog 2 (C. elegans), [RH, Score=232, Expect=8e-64]} {Dmel: FBgn0039883, RhoGAP100F, Rho GTPase activating protein at 100F, [Score=264, Expect=1e-74]} {Celegans: WBGene00006363, syd-1, Rho GTPase-activating protein syd-1, [Score=199, Expect=2e-54]} {Smed: dd_Smed_v6_12363_0_1, dd_Smed_v6_12363_0_1, [Score=382, Expect=4e-117]} {RNA1509_36084} {RNA1310_10433} {RNA815_13685} Mlig455_068666 {REF} {Length: 2783} {Pfam: RhoGAP domain [PF00620.29, score=103.4]} {Human: ENSG00000097096, SYDE2, synapse defective Rho GTPase homolog 2, [Score=208, Expect=6e-57]} {Mouse: ENSMUSG00000036863, Syde2, synapse defective 1, Rho GTPase, homolog 2 (C. elegans), [Score=206, Expect=1e-56]} {Dmel: FBgn0039883, RhoGAP100F, Rho GTPase activating protein at 100F, [Score=229, Expect=4e-64]} {Celegans: WBGene00006363, syd-1, Rho GTPase-activating protein syd-1, [Score=179, Expect=3e-48]} {Smed: dd_Smed_v6_12363_0_1, dd_Smed_v6_12363_0_1, [Score=332, Expect=4e-101]} {RNA1509_36084} {RNA1310_10433} {RNA815_13685} |
65. | MligTC455_48606 | 181 | 3.78 | Mlig455_057120 | Neo: - Age: - Region-enriched R2: 2.436/0.01920 |
ENSA | 0.95 | - | - | - | - | 0.950 | - | Mlig455_057120 {REF} {Length: 3083} {TRANSSPLICED} {Pfam: cAMP-regulated phosphoprotein/endosulfine conserved region [PF04667.19, score=33.5]} {Human: ENSG00000143420, ENSA, endosulfine alpha, [RH, Score=79.7, Expect=2e-19]; ENSG00000128989, ARPP19, cAMP regulated phosphoprotein 19, [RH, Score=79.3, Expect=3e-19]} {Mouse: ENSMUSG00000038619, Ensa, endosulfine alpha, [RH, Score=80.9, Expect=4e-20]} {Dmel: FBgn0061515, endos, endosulfine, [RH, Score=67.8, Expect=4e-15]} {Smed: dd_Smed_v6_4126_0_2, dd_Smed_v6_4126_0_2, [Score=82.8, Expect=4e-21]} {RNA1509_39694} {RNA1310_16598, RNA1509_39694} {RNA1509_39694, RNA815_33532} |